{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:03:52Z","timestamp":1780556632945,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.neulet.2005.11.050","type":"journal-article","created":{"date-parts":[[2005,12,28]],"date-time":"2005-12-28T10:00:24Z","timestamp":1135764024000},"page":"1-4","source":"Crossref","is-referenced-by-count":32,"title":["Trifluoperazine, an orally available clinically used drug, disrupts opioid antinociceptive tolerance"],"prefix":"10.1016","volume":"397","author":[{"given":"Lei","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep K.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaijie Jim","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2005.11.050_bib1","first-page":"484","article-title":"Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice","volume":"277","author":"Bilsky","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2005.11.050_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0169-328X(00)00265-5","article-title":"Colocalization of the mu-opioid receptor and calcium\/calmodulin- dependent kinase II in distinct pain-processing brain regions","volume":"85","author":"Bruggemann","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neulet.2005.11.050_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1124\/mol.56.1.39","article-title":"Inhibition of calcium\/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence","volume":"56","author":"Fan","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neulet.2005.11.050_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0304-3959(99)00281-X","article-title":"Spinal PKC activity and expression: role in tolerance produced by continuous spinal morphine infusion","volume":"85","author":"Granados-Soto","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2005.11.050_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2042-7158.1973.tb10640.x","article-title":"Differential effects on mouse brain catecholamine turnover of chlorpromazine, trifluoperazine and closely-related non-tranquillizing analogues","volume":"25","author":"Green","year":"1973","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.neulet.2005.11.050_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1146\/annurev.biochem.71.110601.135410","article-title":"Neuronal CA2+\/calmodulin-dependent protein kinase II: the role of structure and autoregulation in cellular function","volume":"71","author":"Hudmon","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neulet.2005.11.050_bib7","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1046\/j.1471-4159.1997.69041767.x","article-title":"Site mutation in the rat mu-opioid receptor demonstrates the involvement of calcium\/calmodulin-dependent protein kinase II in agonist-mediated desensitization","volume":"69","author":"Koch","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2005.11.050_bib8","first-page":"458","article-title":"Trifluoperazine attenuates naloxone-precipitated symptoms in morphine-dependent rats and mice","volume":"17","author":"Liang","year":"2001","journal-title":"Chin. Pharmacol. Bull."},{"key":"10.1016\/j.neulet.2005.11.050_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0304-3959(95)00073-2","article-title":"Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions","volume":"62","author":"Mao","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2005.11.050_bib10","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1523\/JNEUROSCI.15-03-02396.1995","article-title":"The human mu opioid receptor: modulation of functional desensitization by calcium\/calmodulin-dependent protein kinase and protein kinase C","volume":"15","author":"Mestek","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2005.11.050_bib11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2125.1983.tb01515.x","article-title":"Kinetics of oral trifluoperazine disposition in man","volume":"15","author":"Midha","year":"1983","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neulet.2005.11.050_bib12","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1476-5381.1968.tb07058.x","article-title":"The effect of antidepressants and \u201ctranquilizers\u201d on the response of mice to ethanol","volume":"34","author":"Milner","year":"1968","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neulet.2005.11.050_bib13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0014-2999(94)90817-6","article-title":"A protein kinase inhibitor, H-7, inhibits the development of tolerance to opioid antinociception","volume":"271","author":"Narita","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2005.11.050_bib14","first-page":"389","article-title":"Effects of acute and chronic morphine treatment of calmodulin activity of rat brain","volume":"22","author":"Nehmad","year":"1982","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neulet.2005.11.050_bib15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1254\/jjp.84.412","article-title":"Increase of calmodulin III gene expression by mu-opioid receptor stimulation in PC12 cells","volume":"84","author":"Niu","year":"2000","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.neulet.2005.11.050_bib16","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1124\/jpet.302.3.1002","article-title":"Differential effects of mu-opioid receptor ligands on Ca(2+) signaling","volume":"302","author":"Quillan","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2005.11.050_bib17","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1139\/o83-118","article-title":"Pharmacological antagonism of calmodulin","volume":"61","author":"Roufogalis","year":"1983","journal-title":"Can. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neulet.2005.11.050_bib18","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/sj.bjp.0701012","article-title":"The effects of recombinant rat mu-opioid receptor activation in CHO cells on phospholipase C, [Ca2+]i and adenylyl cyclase","volume":"120","author":"Smart","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neulet.2005.11.050_bib19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.bjp.0702771","article-title":"Involvement of phospholipid signal transduction pathways in morphine tolerance in mice","volume":"128","author":"Smith","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neulet.2005.11.050_bib20","doi-asserted-by":"crossref","first-page":"22081","DOI":"10.1074\/jbc.274.31.22081","article-title":"Calmodulin binding to G protein-coupling domain of opioid receptors","volume":"274","author":"Wang","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2005.11.050_bib21","doi-asserted-by":"crossref","first-page":"L339","DOI":"10.1016\/0024-3205(94)90022-1","article-title":"Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence","volume":"54","author":"Wang","year":"1994","journal-title":"Life Sci."},{"key":"10.1016\/j.neulet.2005.11.050_bib22","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1523\/JNEUROSCI.21-05-01779.2001","article-title":"Pronociceptive actions of dynorphin maintain chronic neuropathic pain","volume":"21","author":"Wang","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2005.11.050_bib23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0014-2999(03)01484-5","article-title":"Reversal of morphine antinociceptive tolerance by acute spinal inhibition of Ca(2+)\/calmodulin-dependent protein kinase II","volume":"465","author":"Wang","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2005.11.050_bib24","first-page":"106","article-title":"Animal studies comparing the neuropharmacological profile of a trifluoperazine HCl-amobarbital combination with that of the individual components","volume":"179","author":"Wardell","year":"1969","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.neulet.2005.11.050_bib25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejphar.2004.01.002","article-title":"Calmodulin inhibitor trifluoperazine attenuates the development and expression of morphine-induced conditioned place preference in rats","volume":"486","author":"Ye","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2005.11.050_bib26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0304-3959(01)00353-0","article-title":"Reduced development of tolerance to the analgesic effects of morphine and clonidine in PKC gamma mutant mice","volume":"94","author":"Zeitz","year":"2001","journal-title":"Pain"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394005013716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394005013716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T11:48:05Z","timestamp":1555069685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394005013716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":26,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0304394005013716"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2005.11.050","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}